In some ways, it’s looking backward but that’s to the benefit of Occidental Petroleum (NYSE:OXY). Had the Democrats won big last year, presumably, enterprises associated with electric vehicles ...

Occidental Petroleum (OXY), which belongs to the Zacks Oil and Gas - Integrated - United States industry, could be a great candidate to consider. This oil and gas exploration and production ...

In this article, we are going to take a look at where Occidental Petroleum Corporation (NYSE:OXY) stands against other best energy dividend stocks to buy right now. The energy sector’s presence ...

Occidental Petroleum (OXY) closed the latest trading day at $50.20, indicating a -0.69% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York ...

What Happened: Purdue Pharma developed and aggressively marketed OxyContin starting in the 1990s via medical sales reps whose job was to convince doctors to prescribe more of their drug.

Purdue Pharma and the family that owns the company have agreed to pay up to $7.4 billion to settle lawsuits filed over the toll OxyContin has taken. The amount agreed upon is more than what was ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to US$7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Members of the family who own Connecticut-based OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller ...